Dr. Heather Wakelee is a Professor of Medicine in the Division of Oncology at Stanford University. She is the faculty director of the Stanford Cancer Clinical Trials Office. Dr.Wakelee is a graduate of Princeton University and Johns Hopkins University School of Medicine and completed her post-graduate training at Stanford University. She has authored or co-authored over 200 medical articles on lung cancer and other thoracic malignancies including thymic malignancies and is involved in dozens of clinical trials related to lung cancer therapy and diagnostics in addition to collaborative efforts in population sciences. She is passionate about mentorship and is dedicated to multidisciplinary care and is delighted to work with an amazing team of nurses, APPs, clinical research coordinators and physician colleagues. Dr. Wakelee has been an active ECOG-ACRIN (a cancer research group) investigator for her entire academic career. Many of her early publications were secondary analyses of EA trials. She was the study chair of E1505, a phase III trial involving 1500 patients who received adjuvant therapy after resection of early stage non-small cell lung cancer. Although the clinical trial was negative, important biomarker analyses are ongoing. She is currently the thoracic committee co-chair and a member of the EA executive committee. In 2015 she was awarded the EA Young Investigator Award. Dr. Wakelee is also active in ASCO and received the Fellow of ASCO (FASCO) award in 2019. Another critical part of Dr. Wakelee’s career is her work with the International Association for the Study of Lung Cancer (IASLC). She previously served on the IASLC Board of Directors, as Chair of the Communications Committee, as a USA Regent and as co-chair of the NACLC (formerly Chicago Multidisciplinary Symposium in Thoracic Oncology). Recently Dr. Wakelee was elected to become the President-Elect of IASLC and after two years in this role with active work on the executive committee, she will become President in 2021. We are honored to have Dr. Wakelee as an AMPSAA member and speaker at CIMS-Onocology Therapeutic Options 2019 in Beijing, China.